Advanced search
Publication Cover
Future Oncology Volume 17, 2021 - Issue 35
Submit an article Journal homepage
3,608
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Real-World Ibrutinib dose Reductions, Holds and Discontinuations in Chronic Lymphocytic Leukemia

Jing-Zhou Hou1 University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center,Pittsburgh,PA15232,USACorrespondence[email protected]
View further author information
,
Kellie Ryan2 US Medical Affairs, AstraZeneca,Gaithersburg,MD20878,USAView further author information
,
Senxi Du3 Keck School of Medicine,Los Angeles,CA90033,USAView further author information
,
Bruno Fang4 Regional Cancer Care Associates,East Brunswick,NJ08816,USAView further author information
,
Stanley Marks1 University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center,Pittsburgh,PA15232,USAView further author information
,
Ray Page5 The Center of Cancer & Blood Disorders,Fort Worth,TX76104,USA;6 Quality Cancer Care Alliance Network,Tacoma,WA98405,USAView further author information
,
Eileen Peng4 Regional Cancer Care Associates,East Brunswick,NJ08816,USAView further author information
,
Keith Szymanski7 US Market Access, AstraZeneca,Gaithersburg,MD20878,USAView further author information
,
Sharon Winters1 University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center,Pittsburgh,PA15232,USAView further author information
&
Hannah Le2 US Medical Affairs, AstraZeneca,Gaithersburg,MD20878,USAView further author information
 show all
Pages 4959-4969 | Received 06 Aug 2021, Accepted 20 Oct 2021, Published online: 16 Nov 2021

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.